News

November 3, 2020November 3, 2020

Zejula Approved in Europe as Maintenance Therapy for Advanced Ovarian Cancers

News

The European Commission has approved Zejula (niraparib) as a first-line maintenance therapy for people with advanced ovarian, fallopian tube, or primary peritoneal cancer, who respond to platinum-based chemotherapy. This decision ... Read more

October 29, 2020October 29, 2020

3 Companies Join Forces to Test Personalized ‘Teaching’ Vaccine for Ovarian Cancer

News

TransGene, NEC, and BostonGene have entered a strategic collaboration to test TG4050, an investigational personalized vaccine that aims to treat ovarian and head and neck cancers, according to a press release. TG4050 ... Read more

October 27, 2020October 27, 2020

Pilot Study Grants Available for Ovarian Cancer Research

News

Under its Pilot Study Awards program, the Rivkin Center is funding innovative research projects that seek to expand current knowledge about ovarian cancer, the non-profit has announced. Awarded grants will ... Read more

October 22, 2020October 22, 2020

FDA Places PC14586, for Cancers with Mutant Protein, on Fast Track

News

The U.S. Food and Drug Administration (FDA) has granted fast track designation to PC14586 as a potential treatment of advanced cancers that harbor a specific mutation affecting the protein p53, ... Read more

October 20, 2020October 20, 2020

Phase 1 Trial of SL-172154 in Treating Advanced Ovarian Cancer Opens

News

Shattuck Labs has opened a Phase 1 clinical trial to investigate its lead candidate, SL-172154, in treating people with advanced ovarian cancer, the company announced in a press release. The trial ... Read more

October 15, 2020October 15, 2020

First Trial in New NCI-Zenith Partnership Will Test ZEN-3694 Combo for Resistant OC

News

The first clinical trial resulting from a new Zenith Epigenetic collaboration with the National Cancer Institute (NCI) will soon test a combination of the investigational therapy ZEN-3694 plus the immune ... Read more

October 13, 2020October 13, 2020

OCRA Partners With Microsoft AI Initiative to Accelerate Ovarian Cancer Research

News

The Ovarian Cancer Research Alliance (OCRA) has partnered with Microsoft‘s AI for Health initiative, with the ultimate goal of accelerating ovarian cancer research using data science and artificial intelligence (AI). ... Read more

October 8, 2020October 8, 2020

Lab-Grown 3D Tumor Model Provides New Tool to Study Ovarian Cancer, Treatments

News

A lab-grown, three-dimensional (3D) ovarian tumor model will give researchers a new way to study tumor growth in ovarian cancer and to test how tumors might respond to treatments, scientists ... Read more

October 6, 2020October 6, 2020

Lynparza Lowers Risk of Disease Progression in Advanced Ovarian Cancer, 5-year Data Show

News

When used as a first-line therapy to treat newly diagnosed women with advanced ovarian cancer who previously responded to platinum-based chemotherapy, Lynparza (olaparib) prolonged the time they lived without showing signs of ... Read more

October 1, 2020October 1, 2020

Fertility-sparing Surgery Can Effectively Treat Borderline Ovarian Tumors, Study Shows

News

Fertility-sparing surgery can effectively treat borderline ovarian tumors (BOTs), while preserving a woman’s ability to conceive and bear children, a new study suggests. The study, “Reproductive and obstetrical outcomes with ... Read more